Sauty A, Rochat T, Schoch O D, Hamacher J, Kurt A M, Dayer J M, Nicod L P
Dept of Internal Medicine, University Hospital, Geneva, Switzerland.
Eur Respir J. 1997 Dec;10(12):2907-12. doi: 10.1183/09031936.97.10122907.
Interstitial lung disease (ILD) is a complication of polymyositis (PM) and dermatomyositis (DM). It often manifests itself in association with myositis-specific antisynthetase autoantibodies, among which anti-Jo-1 antibodies are the most commonly encountered. In contrast, ILD associated with anti-Jo-1 antibodies without muscle involvement is rare and not well characterized. We report four patients presenting with ILD associated with anti-Jo-1 antibodies. Histological findings of transbronchial biopsies disclosed a pattern consistent with nonspecific interstitial pneumonitis, a CD8+ lymphocytosis was found in bronchoalveolar lavage. Only one of these patients developed an "antisynthetase syndrome" with PM, after nearly 2 yrs of severe ILD. The clinical conditions of all four cases showed stabilization or improvement when cyclosporine was added to their immunosuppressive treatment. These cases confirm that a CD8+ lymphocytic interstitial lung disease may be the first, and sole manifestation of autoimmune disease associated with anti-Jo-1 antibodies. Furthermore, they suggest that this form of interstitial lung disease apparently has a poor response to steroids and cytotoxic drugs, but may respond to moderate doses of cyclosporine and azathioprine in addition to low doses of steroids.
间质性肺病(ILD)是多发性肌炎(PM)和皮肌炎(DM)的一种并发症。它常与肌炎特异性抗合成酶自身抗体相关联出现,其中抗Jo-1抗体最为常见。相比之下,与抗Jo-1抗体相关且无肌肉受累的ILD较为罕见,其特征也不明确。我们报告了4例出现与抗Jo-1抗体相关的ILD患者。经支气管活检的组织学结果显示出与非特异性间质性肺炎一致的模式,支气管肺泡灌洗中发现CD8 +淋巴细胞增多。在严重ILD近2年后,这些患者中只有1例出现了伴有PM的“抗合成酶综合征”。当在免疫抑制治疗中加入环孢素时,所有4例患者的临床状况均显示稳定或改善。这些病例证实,CD8 +淋巴细胞性间质性肺病可能是与抗Jo-1抗体相关的自身免疫性疾病的首发且唯一表现。此外,它们表明这种形式的间质性肺病显然对类固醇和细胞毒性药物反应不佳,但除低剂量类固醇外,可能对中等剂量的环孢素和硫唑嘌呤有反应。